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Differential effects of acute mineralo- and glucocorticosteroid adminis-
tration on renal acid elimination. Unanesthetized, adrenalectomized rats
(ADX), maintained on saline to drink and a low potassium diet, were
given either vehicle alone or graded doses of aldosterone or dexametha-
sone (both singly and in combination) to determine the effects of
mineralo- and glucocorticosteroids on renal acid excretion. Rates of
phosphate excretion (U,V), titratable acid (UTAY) and ammonia
(UammV), and urine pH (UH) were measured following ammonium
chloride and sodium phosphate loading. Aldosterone produced a dose-
dependent fall in UH yet increased UTAV only modestly because of a
fail in U1V. It did not modify UammV. Consequently, aldosterone
increased net acid excretion only marginally. Dexamethasone did not
alter UH significantly. However, it increased substantially the excre-
tion of buffer as phosphate and ammonia and, by the highest dose, more
than doubled net acid excretion. The creatinine clearance of ADX rats
receiving the highest dose of dexamethasone was 87% higher than those
receiving the highest dose of aldosterone. The fall in blood pH and
bicarbonate following ammonium chloride gavage was similar in ADX
rats whether or not they were given aldosterone, yet it was significantly
attenuated by dexamethasone. This indicates that the predominant
effects of dexamethasone was to promote net acid excretion rather than
to augment acid production. In other studies, phosphate was adminis-
tered to SHAM rats and ADX rats given 20 g/100g of dexametha-
sone to vary urinary buffer delivery over a 100-fold range. The UTAV
increased in strict proportion to UnV in both groups without indication
of a limit to hydrogen ion secretion even in the absence of aldosterone.
At comparable urinary phosphate buffer concentrations, UH was
always lower in ADX rats given aldosterone than those given dexa-
methasone. Thus, in the acid-loaded rat, two classes of corticosteroids
have dose-dependent and discrete actions on the components of renal
acid excretion. Mineralocorticosteroids promote urinary acidification
whereas glucocorticosteroids promote the excretion of buffer as phos-
phate and ammonia.
Effets differents de l'administration aiguë de minéralo ou de glucocorti.
costéroides sur l'élimination rénale des acides. Des rats éveillés surréna-
lectomisés (ADX) buvant du solute physiologique et recevant un régime
pauvre en potassium ont recu soit le véhicule seul, soit des doses
croissantes d'aldostérone ou de dexamethasone (seules ou combinCes)
pour determiner l'effets des minCralo et des glucocorticostéroIdes sur
l'excrCtion rCnale des acides. L'excrCtion urinaire des phosphates
(UpV), d'acidité titrable (UTAV) et d'ammoniaque (UmmV) et le pH
urinaire (UPH) ont été mesurés aprCs une surcharge en chlorure
d'ammoniaque et en phosphate de sodium. L'aldostérone a entrainé
une chute de UPH dose-dCpendante mais n'a élevC UTAV que modéré-
ment en raison d'une baisse de UpV. Elle n'a pas modiflé UammV.
L'aldostérone n'a donc augmente l'excrCtion acide nette que de facon
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marginale. La dexamethasone n'a pas modifié significativement UH.
Cependant, elle a substantiellement augmenté l'excrétion de tampon
sous forme de phosphate et d'ammoniaque, et, a Ia plus forte concentra-
tion, a plus que double l'excrétion acide nette. La clearance de La
crCatinine des rats ADX recevant la dose maximale de dexamethasone
Ctait de 87% plus élevée que ceux recevant La dose maximale d'aldostCr-
one. La chute du pH et des bicarbonates plasmatiques aprés gavage
avec du chlorure d'ammoniaque Ctait identique chez les rats ADX
recevant ou non de l'aldostérone, mais était significativement attCnuCe
par Ia dexamCthasone. Cela indique que l'effet predominant de Ia
dexamCthasone Ctait plus d'augmenter l'excrétion acide urinaire nette
que d'augmenter Ia production d'acides. Dans d'autres etudes, des
phosphates ont Cte administrCs a des rats contrôles ou a des rats ADX
recevant 20 g/100g de dexamethasone afin de faire varier de I a 100
l'apport urinaire de tampons. UTAV s'est ClevCe de facon strictement
proportionnelle a uv dans les deux groupes sans indice d'une limite a
Ia sécrCtion d'ions de hydrogene, mCme en l'absence d'aldostCrone.
Pour des concentrations identiques de tampons phosphates urinaires,
UPH Ctait toujours plus faible chez les rats recevant de l'aldostérone que
chez ceux recevant de La dexamethasone. Ainsi, chez le rat surcharge
en acide, les deux classes de corticostCroides possèdent des effets
discrets et dose-dépendants sur l'excrétion acide rénale. Les minCralo-
corticostCroIdes stimulent l'acidification urinaire, tandis que les glucor-
tocitostCroides stimulent l'excrCtion de tampons phosphate et ammon-
iaque.
It has long been recognized that the adrenal cortex is essen-
tial for normal acid-base homeostasis [1]. Studies of human
subjects with adrenal insufficiency [1—3] and of adrenalecto-
mized (ADX) animals [4—131 have shown that a metabolic
acidosis often develops and that maximal rates of excretion of
titratable acid (UTAV) and ammonia (UammV) are diminished
and minimal values of urine pH (UH) may not be achieved.
Although adrenal hormones are necessary for maintenance of
normal acid-base balance, especially during acid loading, it is
unclear which class of adrenal hormones are required to modu-
late the different components of renal acid elimination. Thus,
studies in subjects with adrenal failure [2, 12], ADX rats [4] and
ADX dogs [51 given glucocorticosteroids to establish a selective
mineralocorticosteroid deficiency indicate that renal acid elimi-
nation can be augmented by mineralocorticosteroids. Yet,
patients with adrenal failure or ADX rats can sometimes be
maintained simply on glucocorticosteroids or salt without de-
veloping metabolic acidosis [2, 8, 9]. Moreover, in the ADX rat,
renal acid elimination can be increased by dexamethasone
during acute or prolonged acid loading [6], and in the normal or
glucocorticosteroid-deficient dog acid excretion can be in-
creased substantially by glucocorticosteroids [7, 14].
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There are several indirect effects of corticosteroid adminis-
tration on renal acid elimination that could have complicated
the interpretation of some previous studies: (1) Repeated ad-
ministration of glucocorticosteroids can increase endogenous
acid production with secondary effects on acid excretion [7]. (2)
Glucocorticosteroids can increase the excretion of sodium
(UNaV), potassium (UKV), and phosphate (U1V) [5—7] possibly
enhancing acid elimination [8, 18—20]. (3) Prolonged administra-
tion of mineralocorticosteroids can lead to potassium depletion
which in the rat is a potent stimulus to ammoniagenesis [21, 22]
and in the dog potentiates the effects of mineralocorticosteroids
on renal acid excretion [23, 24]. (4) Mineralo- and glucocorti-
costeroids can interact with each other's receptors [25, 26].
Our aim was to examine how specific mineralo- and glucocor-
ticosteroids modulate acid elimination. Hormones of each class
were given in graded doses to ADX rats following an acid and
buffer load; acid excretion was assessed from measurements of
urine pH (UH), excretion of titratable acid (UTAV), ammonia
(UammV), bicarbonate (UHCO3V) and phosphate (U1V) over the
period 1 to 4 hr later.
A preliminary report of this work has been published [27].
Methods
The model chosen to investigate the effects of hormone
administration on acid elimination was the ADX rat studied 3 to
6 days after operation when results could not be influenced by
basal levels of corticosteroids. Acid elimination was stimulated
by the administration of acid (ammonium chloride) and buffer
(neutral sodium phosphate). Steroids were given acutely to
minimize secondary effects on the kidney caused, for example,
by altered fluid and electrolyte balances or metabolic effects.
Large numbers of experiments were required to obtain full
dose-response relationships for mineralo- and glucocorticoster-
oids to assess the specificity of the actions of these hormones.
In addition, to examine whether a steroid of one class might be
required to permit full expression of the effects of a steroid of
the other class, the dose-response relationships for each steroid
were redefined in the presence of a fixed dose of the steroid of
the other class. Confirming previous studies (6, 11, 28), aldos-
terone was found in preliminary experiments to exert its
maximal renal actions within 6 hr and was given 2 hr before
urine collection. The effects of dexamethasone required a
longer time to develop (7, 11, 29); it was given twice, 15 and 2 hr
before urine collection.
We elected to study conscious, nontraumatized animals to
reduce further stress on these fragile animals by anesthesia and
acute surgical intervention which might otherwise have domi-
nated their renal performance. Sham-operated rats (SHAM)
were included so we could observe renal acid elimination in rats
with intact adrenal glands. However, adrenalectomy has pro-
found effects on renal and cardiovascular function, as well as on
fluid and electrolyte balance which also affects renal acid
excretion. Although dietary intakes were regulated to minimize
differences between the ADX and SHAM groups, these varia-
bles were not perfectly matched; consequently, any differences
between SHAM and ADX rats reflect not only the effects of the
elimination of steroid action on the kidney but also the more
widespread effects of adrenal insufficiency, per se. Our study's
main emphasis rests on comparisons of renal acid excretion
between identical groups of ADX rats given vehicle alone or
graded doses of a specific steroid class.
Adrenalectomized rats were maintained on a high sodium
chloride and low potassium intake to counteract the major
electrolyte complications of adrenalectomy, namely, salt deple-
tion and potassium retention. We assessed the effects of these
dietary manipulations on the food intake and fluid and electro-
lyte excretion in separate groups of SHAM and ADX rats
housed in metabolic cages for 3 days following surgery.
In parallel studies, we obtained aortic blood from rats sacri-
ficed either before or after gavage to assess the effects of gavage
and hormone administration on blood acid-base status and
blood chemistry.
Because adrenalectomy can alter both UH and phosphate
excretion [2—6, 17], we performed additional experiments to
investigate initially the extent to which any changes in UH are
determined by the urinary buffer concentration and secondly,
whether or not the capacity to secrete hydrogen ion (assessed
from titratable acid excretion) is limited in aldosterone-deficient
rats when the urinary buffer delivery is increased. Renal buffer
excretion was varied in these experiments by changing the
phosphate content of the gavage solution but keeping constant
its volume and ammonium chloride content.
Male Sprague-Dawley rats (N = 224) weighing 150 to 250 g
were anesthetized with ether, and their adrenal glands were
exposed by bilateral subcostal incisions. Rats were either
adrenalectomized or subjected to sham operations (SHAM).
ADX rats were maintained on a potassium-deficient diet (Tek-
lad, #170550) composed of the following in g/kg* casein, 200;
sucrose, 656; cellulose, 20; corn oil, 70; vitamin mix, 9; and
mineral mix (#170830), 40, providing the composition of sodi-
um, 0.42%; potassium, 0.0025%; inorganic phosphate, 0.586%;
calcium, 0.92%; chloride, 0.30%; and sulfur, 0.21%. They were
all given a solution of 154 m sodium chloride and 93 ifiM
ammonium chloride to drink. SHAM rats were maintained on
the same diet as the ADX rats but with a higher potassium
chloride content (potassium, 7.89%) and a solution of 93 mM
ammonium chloride to drink.
We studied the following groups of rats with these objectives
in mind:
To observe the effects of adrenalectomy on food intake and
fluid and electrolyte excretion in the basal state, we housed 7
SHAM and 7 ADX rats in metabolic cages for 3 days after
surgery. We measured the quantity of food eaten and the
cumulative excretions of fluid, sodium, potassium, and phos-
phorus. Urine samples were collected under oil.
To study the renal excretion of acid following an acid and
buffer load, we gave rats 5 mlIlOOg of body wt of a solution
containing 187 mM ammonium chloride, 95 mti dibasic sodium
phosphate and 19 ms monobasic sodium phosphate (pH = 7.2)
by gavage on days 3 and 6 following surgery. One hr later, we
placed the rats in metabolic cages and collected urine samples
passed over the subsequent 3 hr under oil.
To observe acid excretion in the absence of administered
steroids, we gave 7 SHAM and 12 ADX rats i.m. injections of
vehicle alone (0.2 ml of 154 m sodium chloride solution) 2 hr
before commencing urine collections.
To study the effects of aldosterone or dexamethasone individ-
ually on acid excretion, we divided ADX rats into 8 groups, 4 of
which received aldosterone (d-aldosterone; Sigma) and 4 re-
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Table 1. Change in body weight, food intake, and fluid and electrolyte excretion after operationa
SHAM,N =7 ADX,N=7 Pvalue
Body wt, g/3d + 5.2 6.9 + 9.1 3.4 NS
Food intake, g/3d 38 11 29 5 NS
UV, ml/3d' 93 45 90 31 NS
UNaV, mmoles/3d 3.9 1.8 18.7 7.4 <0.001
UKV, mmoles/3d 26.4 14.6 1.1 0.4 <0.001
U5.V, mmolesI3d 0.46 0.23 0.07 0.06 <0.001
a Mean SD (N = number of rats) for rats studied in metabolic cages for 3 days after adrenalectomy of SHAM operations. Abbreviations are:
ADX, adrenalectomized rats; SHAM, sham-operated rats; UV, urinary excretion; UNaV, urinary excretion of sodium; UKV, urinary excretion of
potassium, UnY, urinary phosphate excretion; NS, not significant.
ceived dexamethasone (dexamethasone-2 1 -orthophosphate;
Fortecortin, Merck). The aldosterone doses studied (g/100g of
body wt') were 0.01, 0.1, 1.0, and 10; the dexamethasone
doses studied (g/100g of body wt) were 0.02, 0.2, 2.0, and
20.
To observe whether renal acid excretion of ADX rats required
hormones of both classes, we divided rats into a further eight
groups. In four groups, the same aldosterone doses were
studied but in addition to a fixed dose of 0.2 p.g/lOOg of body
wt of dexamethasone. Similarly, in the other four groups, the
same dexamethasone doses were studied but in addition to a
fixed dose of 1.0 p.g/lOOg of body wt' of aidosterone. Hormone
injections were given intramuscularly.
We studied all rats on days 3 and 6 following adrenalectomy.
The highest doses of aldosterone and dexamethasone were not
used on day 3. As a further precaution to prevent any systemat-
ic bias due to a possible "carry-over" effect of the hormones,
we gave rats that had received aldosterone on day 3 dexametha-
sone on day 6 and vice versa. Thus, each rat received both
aldosterone and dexamethasone, but the order in which these
hormones were administered was randomized.
To study the composition of aortic blood, we performed
parallel experiments in subgroups of rats. We studied the
following rat groups 3 days after surgery: SHAM, ADX, ADX
+ aldosterone (10 xg!100g') and ADX + dexamethasone (20
p.g/i00g'). In each group, one-half of the animals were studied
3.5 to 4.5 hr following gavage with the ammonium chloride and
phosphate solution (see above); one-half received no gavage.
Mean values (± SEM) for each group were calculated and
compared by Students t test, and significant differences were
taken to be P < 0.05.
We obtained the first milliliter of aortic blood for blood gas
estimation using a radiometer blood gas analyzer. Plasma and
urine sodium and potassium concentrations were estimated by
an IL 410 flame photometer, phosphate by the method of Fiske
and Subbarow [30], and creatinine in an Auto-Analyzer (Tech-
nicon, Tarrytown, New York). Urine pH (UH) was measured
with a glass pH electrode using a Corning® pH meter; total
carbon dioxide was estimated in a Corning® total CO2 meter.
Urine titratable acidity (UTA) was estimated on 0.25 to 1-mi
aliquots by titration to pH 7.2 using 20 m sodium hydroxide
solution. Urinary total ammonia (Uamm) was estimated by the
addition of 0.5 ml of 34% formaldehyde solution, adjusted to pH
7.2 with sodium hydroxide. Formaldehyde reacts with ammonia
according to the formula:
4 NH4 + 6 CH2O —f (CH2)6N4 + 4 H + 6 H20
The ammonium present was estimated from the quantity of
hydrogen liberated by back-titration of the sample to pH 7.2
with a sodium hydroxide solution. Urine total acid (UACLD) was
calculated from the sum of UTA and Uamm. Because none of the
urine samples contained a total carbon dioxide greater than 1
mmole, the UHCO3 was neglected.
Results
Fluids and electrolytes after surgery. As shown in Tables 1
and 2, there were no significant differences between SHAM and
ADX rats for changes in body weight or for food intake and
urine output during the 3 days following surgery. There were no
differences in PNa or Cr between ADX and SHAM rats, but PK
was somewhat lower in the ADX group, although clearly, no
group showed evidence of hypokalemia. The ADX group had a
much greater excretion of sodium and a lesser excretion of
potassium, presumably reflecting the effects of adrenalectomy
and dietary intakes. It should be noted that phosphorus excre-
tion (U,V) was strikingly lower in the ADX group despite a
similar dietary intake.
As shown in Table 2, after gavage with ammonium chloride
and phosphate, the PNa, PK, and PCr were comparable in ADX
and SHAM rats and again, PK was normal in all groups. The
creatinLie clearance of the ADX group was reduced by 27%
below that of the SHAM group. The acute administration of
aldosterone to ADX rats did not modify these variables, but
dexamethasone led to a small rise in PNa and a substantial rise in
creatinine clearance.
Aldosterone and acid excretion. Figure 1 details the renal
excretion of SHAM and ADX rats not given steroid or given
increasing doses of aldosterone with or without a fixed dose of
dexamethasone. Increasing the dose of aldosterone did not
modify urine flow. However, aldosterone led to a dose-related
fall in U and the urine sodium/potassium ratio which was
evident of doses from 0.01 to 0.1 g/100g. The UTAV was
unaltered by aldosterone at the lower doses but, with 10
xg/l00g aldosterone, UTAV increased significantly (P <
0.01). Increasing aldosterone did not modify UammV and led to
only a modest rise in UACIDV which was confined to the highest
dose (P < 0.05). The administration of dexamethasone reduced
the effect of aldosterone on UH and augmented baseline values
of UTAV.
Dexamethasone and acid excretion. Figure 2 details the renal
excretion of SHAM and ADX rats not given steroid or given
increasing doses of dexamethasone with or without a fixed dose
of aldosterone. Dexamethasone clearly increased urine flow
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Table 2. Plasma electrolytes, creatinine, and creatinme clearancea
SHAM ADX ADX&ALDO ADX&DEXA
Without gavage (N 7) (N = 8)
PNa, mmoles/liter 139.5 1.4 138.3 1.1
NS
PK, mmoles/liter 5.37 0.69 4.43 0.53
P < 0.02
PCr, p.moles/liter 23.9 4.4 25.7 1.5
NS
After ammonium chloride and phosphate gavage(N=7) (N=7) (N=8) (N=7)
PNa, mmoles/Iiter' 140.2 3.21 139.4 1.4 140.0 2.8 143.2 1.3
Pvs.ADX NS NS P<0.001
PK, mmoles/liter' 4.30 1.04 3.74 1.53 4.73 0.90 4.72 0.47
Pvs.ADX NS NS NS
PCr, pmoles/liter' 24.1 4.6 23.0 7.1 28.8 8.8 23.1 7.7
Pvs.ADX NS NS NS
Car, mlIminVlOOg' 0.559 0.074 0.408 0.081 0.346 0.040 0.764 0.132(N=6) (N=5) (N=7) (N=7)
P vs. ADX P < 0.05 NS P < 0.001
Mean SD (N = number of rats) for plasma electrolyte concentrations, plasma creatinine, and creatinine clearance of SHAM and ADX rats
given either no corticosteroids, aldosterone (10 g/100g), or dexamethasone (20 g/100g'). Animals were studied 3 days postoperatively.
Abbreviations are: ADX, adrenalectomized rats; SHAM, sham-operated rats; ALDO, aldosterone; DEXA, dexamethasone.
rate. It did not alter significantly. Dexamethasone reduced
the urine sodium:potassium ratio, and the addition of aldoster-
one reduced this further. Despite minimal effects on UPH,
dexamethasone, at doses exceeding 0.2 igIl00g', increased
UTAV substantially and at the 20 g/l00g of body wt dose,
UTAV had increased three-fold. Dexamethasone also led to a
substantial and dose-related increase in UammV that had dou-
bled at the 20 g/l00g dose level. Consequently, dexametha-
sone led to a large increase in total acid elimination. The
addition of aldosterone had only minor effects on acid excretion
during dexamethasone.
Steroids, sodium, and potassium excretion. Table 3 shows
values for UNaV and UKV of SHAM and ADX rats following
acid and phosphate gavage. The UNaV of ADX rats without
steroid replacement did not differ from SHAM rats, but UKV
was reduced by an average of 2.9 moles/min -Vkg' (P <
0.0005). Aldosterone reduced UNaV but increased UKV, where-
as dexamethasone increased both UNaV and UKV. The addition
of a fixed dose of dexamethasone during testing with aldoster-
one tended to increase UNaV and UKV, whereas the addition of
a fixed dose of aldosterone during testing with dexamethasone
tended to increase UKV but only at the lower doses.
Phosphate and urine pH. As shown in Figure 3, the plasma
phosphorus (P1) was similar in SHAM or ADX rats after
gavage and was unchanged by aldosterone or dexamethasone.
However, phosphorus excretion was markedly reduced in ADX
rats compared to SHAM rats both in the basal state (Table 1)
and after the gavage (Fig. 3). While aldosterone administered to
ADX rats led to a small fall in UV, dexamethasone produced
the opposite effect and raised Up1V strikingly to levels 2.5-fold
above ADX rats that did not receive any hormones.
Individual values of UPH following gavage are shown in
Figure 4. The shaded areas represent the mean 2 SD for the
SHAM group. The ADX rats had a uniformly higher UH than
the SHAM rats. There was a consistent difference in UH
between ADX rats given aldosterone and those given dexa-
methasone with all values being lower in the aldosterone-
treated group.
Because the should be considered in relation to the
urinary content of buffers, the relationship between urine pH
and buffer was analyzed further. Thus, the higher UH of ADX
rats given dexamethasone compared to ADX alone or SHAM
rats might be due to the much higher phosphate excretion of the
former group. To investigate this, Upj was varied in groups of
SHAM and ADX rats given dexamethasone (20 g/l00g') by
varying the phosphate concentration of the gavage solution
(from 0 to 113 mM) without varying the ammonium chloride or
volume. As shown in Figure 5, varying Upj over a 50 to 100-
fold range did not modify UPH in either group. For comparison,
the individual values from the ADX rats given aldosterone (10
xgJ100g) that received the standard phosphate and acid
gavage are included also. At comparable levels of urinary
phosphate buffer, the same order existed for UH, that is, in
order of increasing urinary acidity, ADX alone < ADX +
dexamethasone < SHAM <ADX + aldosterone.
In these experiments, the rates of titratable acid excretion
were calculated as described previously [19, 31, 32] from blood
and urine pH and phosphate and creatinine excretion (assuming
a pK for phosphate to be 6.8 and for creatinine, 4.7). They are
shown as a function of phosphate excretion using a log-log plot
in Figure 6. At the lower rates of phosphate excretion, urinary
creatinine accounted for about one third of the total urinary
buffer capacity while at the higher rates of phosphate excretion,
this fraction fell to less than 3%. It is apparent that increasing
urinary buffer delivery over a 100-fold range produced strictly
proportionate increases in UTAY in both SHAM and aldoste-
rone-deficient rats without indication of an upper limit to
hydrogen ion secretion in either group. Differences in Up1V
between groups of rats clearly had much more striking effects
on UTAV than differences in UH. For example, in ADX rats, a
fall in mean values of UH from 5.9 to 5.1 produced by
aldosterone increases UTAV by only 15% while a rise in mean
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Fig. 1. Responses of ADX rats to aldosterone.
Values shown are mean SEM. In each panel
shown first are values from SHAM rats (double
circles); next are results from ADX rats given
no aldosterone and thereafter results (solid cir-
cles) with increasing doses of aldosterone (0.01,
0.1, 1 and 10 gI100g of body wt'). Other rats
received dexamethasone, 0.2 gI100g of body
wt' in addition to aldosterone (solid squares).
The number of rats in each group appears in
parenthesis in panel A.
Fig. 2. Responses of ADX rats to dexametha-
sone. Values shown are mean SEM. In each
panel shown first are values from SHAM rats
(double circles); next are results from ADX rats
given no dexamethasone and thereafter, results
(solid circles) with increasing doses of dexa-
methasone (0.02, 0.2, 2 and 20 g/l00g of body
wt'). Other rats received aldosterone, 1 xg/
lOOg of body wt' in addition to dexamethasone
(solid squares).
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values of Up1V from 4.03 to 10.81 pmoles/min'/kg1 produced
by dexamethasone increases UTAV by more than 10 times as
much.
Effects of gavage and steroids on blood pH, Pco2, and
plasma bicarbonate concentrations. When the ammonium chlo-
ride and phosphate gavage were omitted, there were no differ-
ences in blood pH, Pco2, or PHCO, between the groups of
SHAM and ADX rats with or without steroid administration
(Fig. 7; Table 4). However, 3.5 to 4.5 hr after gavage, blood pH
and PHCO3 were higher in ADX rats that had received dexameth-
asone than those that had received no steroid or aldosterone.
Moreover, ADX rats that received a gavage experienced a fall
in PHCO3 which was reduced by dexamethasone but not by
aldosterone (Fig. 7).
We conclude that the acute administration of mineralo- and
glucocorticosteroids leads to discrete and specific effects on
renal acid elimination in the acidotic ADX rat: Mineralocorti-
costeroids reduce UPH and glucocorticosteroids increase buffer
excretion as phosphate and ammonia. Glucocorticosteroids
were more effective than mineralocorticosteroids in augmenting
net acid excretion and mitigating the effects of acid loading on
blood pH and bicarbonate concentrations.
Adrenalectomy and acid excretion. Sartorius, Caihoon, and
Pitts [4, 12] showed that ADX rats challenged with an ammoni-
urn chloride load had reduced rates of ammonia and titratable
acid excretion, amounting to 50 and 80%, respectively, of
normal and a minimal that was about 0.5 pH units above
the controls. Very similar results were observed in the present
study. Sartorius, Calhoon, and Pitts [4] showed further that the
reduced rates of acid excretion were apparent within 2 hr of
adrenalectomy and persisted for up to 2 months. Reductions in
net acid excretion in ADX rats during basal conditions or acute
and chronic acid loading have been confirmed by several
subsequent studies [6, 8, 9].
In the rat, potassium loading reduced UammV and net acid
excretion [8, 33] while potassium depletion augments it [8, 20—
22, 34]. Because adrenalectomy impairs potassium excretion,
any ensuing potassium retention might lower acid excretion in
the rat [81. We selected the same dietary potassium regimen for
the ADX rats that Dubrovsky Ct al [8] used, that is, a nominally
zero potassium intake. These authors rigorously controlled for
the effects of adrenalectomy on potassium stores, urine flow
rate, UH, food intake, and sodium excretion by pair feeding
and appropriate manipulations of the sodium and potassium
intakes of their SHAM control group. They found that, despite
eliminating the influence of the secondary effects of adrenalec-
torny, net acid excretion in the ADX rats during the ammonium
chloride challenge remained only 60% of the SHAM group.
They concluded that the adrenal gland itself was required for
normal renal acid excretion. It was not the aim of our experi-
ments to investigate further the acidification defects of adrenal-
ALDO
dose
DEXA
dose
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Table 3. Renal sodium and potassium excretiona
N UNaV UKV
7 22.1 10.4 4.4 0.6
0 0 12 16.3 5.8 1.5 0.8
0.01 0 5 15.9 8.3 2.9 1.6
0.1 0 5 10.3 4.4 3.2 2.0
1.0 0 8 6.3 8.1 3.5 1.6
10.0 0 8 3.0 2.7 3.6 1.9
0.1 0.2 10 20.5 5.3 4.2 1.1
1.0 0.2 14 13.7 6.4 4.7 2.2
10.0 0.2 5 9.0 5.0 4.8 1.1
0 0.02 6 15.2 10.6 1.6 2.0
0 0.2 10 19.7 5.2 2.6 1.0
0 2.0 7 23.8 11.1 6.2 2.0
0 20.0 6 33.7 15.8 9.2 2.7
1.0 0.02 8 15.2 6.0 3.8 1.4
1.0 0.2 15 15.4 20.2 5.7 3.0
1.0 2.0 5 31.4 7.5 8.6 1.9
1.0 20.0 5 27.3 12.9 8.0 2.3
SHAM
ADX
a Mean values (± SD) for renal sodium excretion (UNaV, mo1es/min '1kg of body wF 1) and potassium excretion (U1V, iimol/min '1kg of body
wr')in SHAM and ADX rats given varying doses of aldosterone (ALDO) or dexamethasone (DEXA, p.g/lOOg of body wt'); N = number of rats.
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Fig. 3. Mean values (± sEM) of plasma phosphate concentration (P1)
and renal phosphate excretion (U1V) following the gavage. Abbrevia-
tions used are defined in Tables 1—4.
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ectomy; nevertheless, we did find a very similar reduction in
net acid excretion in ADX rats amounting to 50% of the SHAM
group when compared to studies in which precise control of the
secondary effects of adrenalectomy has been attempted [8].
Aldosterone and acid excretion in ADX rats. We found that
aldosterone given to ADX rats led to a dose-dependent fall in
UH. The levels of UPH achieved by the ADX rats given the
highest dose of aldosterone were actually somewhat below
those of the SHAM group. These results confirm previous
I
>
Up V, mo/es/mi,r1/kg'
findings that ADX rats or dogs challenged with an acid load
have higher values of UH than control animals and that this
acidification defect is reversed by mineralocorticosteroids [4, 6,
111. However, DiTella et al [9] observed that the aldosterone-
deficient rat (that is, adrenalectornized and maintained on
dexamethasone) retained a normal ability to lower UPH during
acidosis. The reason for this apparent difference is unclear
although it is possible that the dexamethasone used in the study
of DiTella et al [9] may have masked an effect of aldosterone-
deficiency on U because we observed that a smaller dose of
dexamethasone diminished the effect of aldosterone on UPH.0 Kurtzman, White, and Rogers [10] showed that aldosterone-
deficient dogs failed to reduce UPH normally during Na2SO4
infusion. In more chronic studies of ADX dogs maintained on
mineralo- and glucocorticosteroids, the immediate effect of
discontinuing mineralocorticosteroids was raising the UH [5,
35]. However, with the development of metabolic acidosis, UPH
returned to its previous levels unless hyperkalemia was pre-
vented by dietary potassium restriction when UPH remained
less acid by about 0.3 to 0.4 pH units for up to 15 days [5]. In the
intact dog, prior potassium depletion (5 mmoles/kg ') is re-
quired to demonstrate a fall in UPH produced by mineralocorti-
costeroids [23, 24]. In our study, some degree of potassium
depletion may have occurred in the ADX rats possibly condi-
tioning their response to aldosterone. However, their PK was
normal both before and after gavage. Moreover, adrenalectomy
severely curtails renal potassium elimination. The results of
Dubrovsky et al [8] who measured the potassium balance of
ADX rats fed a nominally zero potassium intake (as in our
study) after operation suggest that our ADX rats lost approxi-
mately 0.9 mmoles/kg of potassium over 3 days or less than
x1x
•SHAM
I xADX
I DADX+DEXA
LoADX + ALDO
.
--
0.1
50
10
I0
0.1
10 g/100 g' 20 i.LgIlOO g1
Fig. 4. Individual values of urine pH following gavage. The shaded area
represents the normal range for the SHAM group. 0.01
'C
0.01 1 10 50
I
Fig. 6. Individual values for the same rats detailed in Figure 6 showing
renal titratable acid excretion as a function of phosphate excretion.
Titratable acid concentration was calculated from the measured values
of blood and urine pH, urine phosphate, and creatinine concentrations
(see Discussion).
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Fig. 5. Individual values of urine pH as a function of urine phosphate
concentration (Up,) shown for SHAM rats and ADX rats given dexa-
methasone (DEXA, 20 g/100g I) following gavage with am,nonium
chloride and varying doses of neutral sodium phosphate and for ADX
rats and ADX rats given aldosterone (ALDO, 10 xg/100g ') following
the standard gavage with ammonium chloride and neutral phosphate.
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SHAM ADX ADX&ALDO ADX&DEXA
Without gavage (N = 7) (N = 8) (N = 7) (N = 6)
Blood pH 7.311 0.065 7.330 0.062 7.329 0.071 7.349 0.047
Pvs.ADX NS NS NS
Blood Pc02 mm Hg
Pvs.ADX
40.1 7.9
NS
41.0 6.9 40.9 5.8
NS
39.4 9.5
NS
PHCO3, mmoles/liter
Pvs.ADX
19.6 1.8
NS
20.6 2.2 20.7 1.8
NS
21.2 0.3
NS
After gavage
Blood pH 7.321 0.049 7.247 0.060 7.234 0.071 7.319 0.050
P vs. ADX <0.025 NS <0.05
Blood Pc0 mm Hg
P vs. A1X
32.0 2.0
<0.01
37.0 3.9 37.5 6.2
NS
36.3 5.4
NS
PHCO3, mmoles/liter'
P vs. ADX
16.2 1.1
NS
15.2 1.5 15.3 2.6
NS
19.2 1.5
<0.001
Mean SD (N = number of rats) for groups of rats studied: Without gavage, 3 days after SHAM operations (SHAM) or adrenalectomy (ADX)
(± administration of aldosterone, ALDO), 10 g/100g—' 3 hr before sampling or dexamethasone (DEXA), 20 gI100g 15 hr and 3 hr before
Sampling); or after gavage, in groups similar to those without gavage but subject to the standard ammonium chloride and phosphate gavage 3.5 to
4.5 hr previously.
1.5% of body stores and should not, therefore, be considered to
be severely potassium depleted.
In adrenalectomized patients, Perez, Oster, and Vaamonde
[2] observed a normal ability to reduce UPH to minimal values
but some impairment in acidification in those with hyporenine-
mic hypoaldosteronism. Sebastian et al [3] studied adrenalecto-
mized subjects maintained on dexamethasone and observed
that administration of mineralocorticosteroids reduced UH in
each patient. Koeppen [36] observed that pretreatment with
mineralocortjcosterojds reduced minimal values for tubular
fluid pH from perfused rabbit cortical collecting tubules, where-
as aldosterone did not affect maximal pH gradients developed
across the urinary bladder of the toad [37, 38]. Also, we
(Wilcox, Granges, Kirk, Gordon, and Giebisch, unpublished
observations) have recently found that DOCA induced a signifi-
cant reduction in late distal tubular fluid pH measured by free-
flow micropuncture methods in the acidotic rat (from 6.51
0.17, N = 10 to 6.21 0.19, N = 5: mean si; P < 0.01).
These observations suggest that mineralocorticosteroids can
increase the maximal tubular fluid-to-blood pH gradients gener-
ated across the distal nephron of the mammal. This response is
specific for mineralocorticosteroids because aldosterone pro-
duced a dose-dependent fall in UPH whereas dexamethasone did
not alter UPH. Because the aldosterone response was apparent
within 2 to 5 hr of administration, it is unlikely to be a secondary
consequence of any major mineralocorticosteroid-induced
changes in fluid or electrolyte balances.
Despite lowering UH, aldosterone increased UTAV only
modestly and had no effect on UammV. Even at the highest
aldosterone dose, net acid excretion was increased only 25%.
Moreover, the falls in blood pH and PHCO3 in ADX rats after
ammonium chloride gavage were not modified by administra-
NS
22
20
18
16
14
12
10
O Before
o After — Difference
.-
P <0.005
P<0.05
VAIl
SHAM
Fig. 7. Mean values (± SEM) ofplasma bicar-
bonate concentration of rats given no gavage
(cross-hatched boxes) or given a gavage 3.5 to
4.5 hr previously (open boxes). The shaded
boxes represent the differences (± 5EM) be-
tween the two groups.
ADX ADX+ALDO ADX+DEXA
10/2g/100g 20ug/t00g7
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tion of the full dose of aldosterone which illustrates further the
rather modest increase in acid elimination produced by aldo-
sterone. In contrast, very large doses of DOCA increased
UammV of acid-loaded ADX rats [41 and UTAV and UammV of
acid-loaded ADX dogs [11]. This increase may perhaps reflect
the fact that large doses of DOCA can also act on glucocortico-
steroid receptors [25, 26] because we found glucocorticoste-
roids to be very potent at increasing UTAV and UammV.
Moreover, the results of the present study confirm those of
Hierholzer, Verde, and Sieke [6] and Peters [13] in ADX rats
which demonstrated that aldosterone fails to restore normal
levels of UammV and UTAV. Furthermore, DiTella et al [91 did
not find a defect in UTAV or UammV in aldosterone-deficient
ADX rats maintained on dexamethasone providing volume
contraction was prevented by saline loading. In normal, acid-
loaded human subjects, the production of selective aldosterone
deficiency by the acute administration of spironolactone in-
creases UH but does not modify UTAV nor UammV [39]. These
results of acute studies during acid loading in man are very
similar to those of the aldosterone-deficient rat in our study.
However, during more prolonged aldosterone deficiency and in
the absence of an acid challenge, a requirement for mineralo-
corticosteroids for normalization of the excretion as ammonia
and titratable acid has been clearly shown in man and dogs [3, 5,
35].
The small effect of aldosterone on UTAV in the present study
was due in part to a fall in U1V. Additionally, the fall in mean
values of UPH from 5.9 to 5.1 produced by aldosterone is far
removed from the pK for phosphate of 6.8. Phosphate is
normally the major urinary buffer, and its relative importance
will have been increased further in the present studies by the
induced phosphaturia. Consequently, the changes in UH pro-
duced by aldosterone in these experiments could not have been
quantitatively important in augmenting UTAV. On the other
hand, where the effects of aldosterone or aldosterone-deficien-
cy are studied in the absence of a large acid load, UH will vary
more closely around the pK for phosphate and in these circum-
stances any changes in UPH will have much more dramatic
effects on UTAV.
Dexamethasone and acid excretion in ADX rats. We found
that dexamethasone given to ADX rats failed to reduce UH
significantly, yet led to large, dose-related increases in
UTAV, and UammV. Consequently, dexamethasone increased
substantially net acid excretion by ADX rats. At the highest
dose, net acid excretion was increased 2- to 3-fold compared to
rats receiving no steroids and was significantly greater (P <
0.01) than ADX rats receiving the highest dose of aldosterone.
There are other studies which indicate an important role for
glucocorticosteroids in augmenting renal acid elimination in the
rat. Thus, Hierholzer, Verde, and Siebe [6] found that 50
ji.g/lOOg of body wt' of dexamethasone restored acid elimina-
tion in ADX rats, whereas 10 pgI100g -' of aldosterone did not.
DiTella et al [9] found that, after controlling for the effects of
salt wasting, potassium retention, and low GFR, acid excretion
by ADX rats given dexamethasone was similar to SHAM rats
even during acid loading.
Our results show that a rise in UTAV occurred with dexa-
methasone without much fall in because of a substantial
increase in phosphate excretion. The results agree with previ-
ous work that has shown that glucocorticosteroids reduce
TMPO4 and increase phosphate excretion [17, 41]. The rise in
UammV with dexamethasone was not explicable simply by the
fall in UPH enhancing ammonium trapping in tubular fluid
because the change in UH was slight and inconsistent. More-
over, aldosterone failed to increase UammV of ADX rats despite
clearly lowering UH. This suggests that ammoniagenesis is
deficient in the glucocorticosteroid-deficient rat [28, 42]. More-
over, glucocorticosteroids can increase ammonia excretion in
the intact animal [7, 14] and ammonia production by perfused
kidneys [28].
The glucocorticosteroid triamcinolone given in high dosage to
ADX dogs maintained on DOCA and salt has recently been
observed increasing the cumulative excretion of ammonia,
titratable acid, and phosphate [7]. This resembles the actions of
dexamethasone in our study. In the dog, however, prolonged
administration of triamcinolone stimulated endogenous acid
production and eventually lowered UH. In our study, dexa-
methasone given over a more acute time course to ADX rats
reduced the fall in blood pH and PHCO, produced by an acid
load, suggesting that increased acid elimination that occurred in
the present experiments after acute dexamethasone administra-
tion to ADX rats is quantitatively more important than any
stimulation of acid production that may also have occurred,
although it is possible that dexamethasone may have altered
PHCO3 by some other mechanism, perhaps by changing hydro-
gen or bicarbonate ion flux across cell membranes. The demon-
stration that dexamethasone, but not aldosterone, could reduce
the fall in blood pH and PHco that followed ammonium
chloride loading in ADX rats testifies to the greater quantitative
importance of dexamethasone in modulating net acid excretion
in these experiments.
Could differences in UNaV modify acid excretion in ADX
rats? This is of relevance because DiTella et al [9] showed that
the aldosterone-deficient rat could excrete acid normally if
given a large saline load. In our experiments, alteration in
sodium balance after steroid administration would be small in
comparison with the large load of sodium given in the gavage
and are thus unlikely to have had prominent effects of acid
excretion. However, UNaV was reduced by aldosterone but
increased by dexamethasone. The increase with dexametha-
sone may be secondary to the increase in GFR but may also be
due to internal shifts of fluid with extracellular fluid volume
expansion [161. We have recently investigated the effects of
volume expansion with saline on renal acid excretion and distal
acidification as assessed from micropuncture measurements of
tubular fluid pH, titratable acid formation, and ammonia secre-
tion [43, 44]. We used intact, acidotic, phosphate-loaded rats
given the same dietary pretreatment (low potassium diet with
saline to drink) as the ADX rats in our study. Substantial
volume expansion with saline increased the distal delivery and
reabsorption of sodium and led to a flow-dependent increase in
UammV and secretion of ammonia into distal tubular fluid.
However, even during chronic, high-dose DOCA administra-
tion, saline infusion did not modify UTAV and at no rate of
distal sodium delivery was there any net addition of titratable
acid to distal tubular fluid. Clearly, therefore, any increased
distal delivery of sodium that might have accompanied dexa-
methasone administration in the present study is unlikely to
have accounted for the rise in UTAV, although it might have
contributed to the rise in UammV, It is also relevant that in the
ADX dog, pretreatment with actinomycin D blocks the stimula-
tion by aldosterone of sodium reabsorption yet leaves unaltered
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its stimulation of hydrogen ion secretion [40]. Thus, the display
of the actions of aldosterone on hydrogen transport are not
obligatorily associated with sodium transport in the mammalian
kidney. Indeed, Koeppen [36] observed that acidification
across the mammalian collecting duct epithelium proceed in the
complete absence of sodium or potassium in the tubular lumen.
Urine pH and buffer concentration. The pH of an acid urine
is determined by the net rate of hydrogen ion addition to tubular
fluid and the urinary buffer content [19, 31, 32]. Thus, the
failure of dexamethasone to reduce UPH of ADX rats might be
explained by its augmentation of buffer excretion as phosphate
or ammonia. To study the importance of urinary buffer concen-
tration in determining UPH, the phosphate load was varied to
provide a wide span of urinary phosphate concentrations. In
groups of both SHAM and ADX rats given dexamethasone,
varying Up1 and the urinary phosphate excretion rate over a
100-fold range produced no change in UH. Thus, the higher
UPH in the dexamethasone-repiaced ADX rats cannot be as-
cribed to increased phosphate buffer excretion. Moreover, the
reversal of this high by aldosterone, likewise, cannot be
ascribed to reduced phosphate buffer excretion because UPH
was clearly below the levels of the ADX group given dexameth-
asone at comparable levels of Upj.
Urinary titratabie acid can be calculated from the urine,
blood pH, and the concentration of fixed buffers of which
phosphate is quantitatively the most important with creatinine
and organic acids making a small contribution [19, 31, 32].
Adrenalectomy does not modify organic acid excretion in the
rat [8]. Thus, we calculated the UTAV from the measured blood
pH, UH, Up, and Ucr to determine whether or not the
secretion of hydrogen as titratable acid by the aldosterone-
deficient rat would saturate at high rates of buffer delivery. It is
clear from Figure 6 that hydrogen ion excretion as titratable
acid can be increased through a 100-fold range during phosphate
loading without any evidence of saturation even in the complete
absence of aldosterone. Moreover, it is apparent from this
figure that a fall in UPH produced by aldosterone administration
to ADX rats increases UTAY only modestly in comparison to
the effects of increased UPIV achieved by dexamethasone
administration which leads to large increases in UTAV.
These acute studies cannot provide a precise definition of the
physiological replacement doses of mineralo- and glucocorti-
costeroids in the ADX rat. Nevertheless, examination of the
dose-response curves shows that aldosterone doses of 0. ito 1.0
xg/l00g and dexamethasone doses of 2 to 20 g/l00g'
restored UV, UPH, UN&K, UTAV, UammV, and UACIDV ofADX
rats to the levels seen in SHAM rats.
Sartorius, Caihoon, and Pitts in 1953 [4] showed that shortly
after induction of a metabolic acidosis, there was a stimulus to
glucocorticosteroid secretion as evidenced by a fall in adrenal
cholesterol and ascorbic acid content. Moreover, metabolic
acidosis in the rat and dog increases plasma aldosterone and
cortisol substantially [8, 45, 46]. The present experiments
demonstrate discreet and physiologically-important actions of
both mineralo- and glucocorticosteroids on renal acid elimina-
tion and therefore, these hormones could play a fundamental
role in modulating acid excretion in metabolic acidosis.
Conclusion. These experiments have shown that mineralo-
corticosteroids specifically increase the maximal urine-to-blood
pH gradient. This is reminiscent of their actions in increasing
the steady-state or maximal sodium and potassium gradients
developed across the superficial distal tubule [47] and collecting
ducts [48]. Despite this effect on urine acidity, net acid excre-
tion during acute metabolic acidosis increased only slightly with
aldosterone because aldosterone did not increase the excretion
of either phosphate or ammonia buffer; the UH was not within
the range of efficient buffering by phosphate. Even in the
absence of aldosterone, titratable acid excretion could be
augmented at least 50-fold by increasing urinary phosphate
buffer delivery, implying that aldosterone deficiency had not
limited hydrogen ion secretion. In contrast, glucocorticoste-
roids specifically increase buffer excretion as phosphate and
ammonia without modifying urinary acidity. Under the experi-
mental conditions of our study, changes in buffer excretion
were quantitatively much more important in dictating renal acid
elimination than changes in urine pH. Consequently, glucocor-
ticosteroids were more potent than mineralocorticosteroids in
augmenting the renal elimination of an acid load and thereby
diminishing acidemia.
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